JAM2
Basic information
Region (hg38): 21:25639258-25717562
Previous symbols: [ "C21orf43" ]
Links
Phenotypes
GenCC
Source:
- basal ganglia calcification, idiopathic, 8, autosomal recessive (Strong), mode of inheritance: AR
- basal ganglia calcification, idiopathic, 8, autosomal recessive (Strong), mode of inheritance: AR
- bilateral striopallidodentate calcinosis (Supportive), mode of inheritance: AD
- basal ganglia calcification, idiopathic, 8, autosomal recessive (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Basal ganglia calcification, idiopathic, 8, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 31851307; 32142645 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- JAM2-related disorder (1 variants)
- Basal ganglia calcification, idiopathic, 8, autosomal recessive (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the JAM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 17 | 19 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 17 | 17 | ||||
Total | 1 | 0 | 17 | 1 | 21 |
Highest pathogenic variant AF is 0.0000197
Variants in JAM2
This is a list of pathogenic ClinVar variants found in the JAM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-25639776-C-A | Benign (May 12, 2021) | |||
21-25639822-A-G | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Pathogenic (Mar 27, 2020) | ||
21-25639842-C-A | Benign (May 04, 2021) | |||
21-25639886-G-A | Inborn genetic diseases | Uncertain significance (Feb 01, 2023) | ||
21-25683787-C-A | Benign (May 12, 2021) | |||
21-25683934-C-T | Inborn genetic diseases | Uncertain significance (Jun 10, 2022) | ||
21-25683938-A-G | Benign (May 04, 2021) | |||
21-25689871-AT-A | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Pathogenic (Mar 27, 2020) | ||
21-25689908-CCAGA-C | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Pathogenic (Mar 27, 2020) | ||
21-25693548-T-C | Benign (May 12, 2021) | |||
21-25693607-A-G | Benign (May 13, 2021) | |||
21-25693777-A-C | Inborn genetic diseases | Uncertain significance (Dec 26, 2023) | ||
21-25693837-G-A | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Pathogenic (Mar 27, 2020) | ||
21-25693837-G-T | Inborn genetic diseases | Uncertain significance (Jan 08, 2024) | ||
21-25698675-A-AG | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Pathogenic (Mar 27, 2020) | ||
21-25698693-A-G | Benign (May 09, 2021) | |||
21-25698706-C-A | Inborn genetic diseases | Uncertain significance (Dec 07, 2021) | ||
21-25698757-G-C | Inborn genetic diseases | Uncertain significance (May 11, 2022) | ||
21-25698786-G-C | Basal ganglia calcification, idiopathic, 8, autosomal recessive | Pathogenic (Mar 30, 2020) | ||
21-25698800-T-C | Inborn genetic diseases | Uncertain significance (Sep 27, 2021) | ||
21-25698803-G-A | Inborn genetic diseases | Uncertain significance (Dec 06, 2022) | ||
21-25698854-C-T | Inborn genetic diseases | Uncertain significance (Apr 19, 2024) | ||
21-25702178-T-C | Likely benign (May 01, 2022) | |||
21-25702222-G-A | Inborn genetic diseases | Uncertain significance (Sep 26, 2023) | ||
21-25702224-A-G | Inborn genetic diseases | Uncertain significance (Oct 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
JAM2 | protein_coding | protein_coding | ENST00000400532 | 10 | 78291 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00615 | 0.990 | 124768 | 0 | 29 | 124797 | 0.000116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.08 | 127 | 166 | 0.764 | 0.00000880 | 1981 |
Missense in Polyphen | 26 | 45.846 | 0.56712 | 567 | ||
Synonymous | 1.95 | 42 | 61.4 | 0.684 | 0.00000323 | 623 |
Loss of Function | 2.53 | 7 | 18.8 | 0.372 | 0.00000106 | 218 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000410 | 0.000410 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000628 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000147 | 0.000141 |
Middle Eastern | 0.0000628 | 0.0000556 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in the processes of lymphocyte homing to secondary lymphoid organs.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Tight junction - Homo sapiens (human);Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Integrin cell surface interactions;Extracellular matrix organization;Cell surface interactions at the vascular wall;Hemostasis;Beta1 integrin cell surface interactions;amb2 Integrin signaling;Alpha4 beta1 integrin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.625
- rvis_EVS
- 0.53
- rvis_percentile_EVS
- 80.73
Haploinsufficiency Scores
- pHI
- 0.0466
- hipred
- N
- hipred_score
- 0.466
- ghis
- 0.419
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.855
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Jam2
- Phenotype
- homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype;
Zebrafish Information Network
- Gene name
- jam2a
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- mononucleate
Gene ontology
- Biological process
- negative regulation of cell adhesion;extracellular matrix organization;leukocyte migration;cell-cell adhesion
- Cellular component
- plasma membrane;integral component of plasma membrane;bicellular tight junction
- Molecular function
- protein binding;protein heterodimerization activity